Raindance Technologies has launched the ASDSeq and XSeq Research Screening Panels for identifying mutations associated with X-chromosome and Autism Spectrum Disorders.
Developed in collaboration with Emory University and Greenwood Genetic Center, the two comprehensive panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD) using next-generation sequencing.
Recent scientific findings indicate that there are more than 800 protein-coding genes on the X chromosome, including many that play a role in autism and other developmental disorders.
To date, the widespread investigation of these genes has been constrained by the high experimental cost of current methods and inadequate analytic resolution.
Commonly used technologies, such as microarrays and real-time PCR, have made it difficult to detect many of the important sequence mutations associated with these complex disorders.
The Raindance ASDSeq panel and XSeq panel are based on the company's microdroplet-based targeted sequencing technology, which features coverage for detecting mutations central to understanding these types of disorders.
